封面
市場調查報告書
商品編碼
1409854

2024 年組織工程全球市場報告

Tissue Engineering Global Market Report 2024

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,組織工程市場規模迅速擴大。將從2023年的133.6億美元擴大到2024年的153.8億美元,複合年成長率為15.1%。在歷史時期觀察到的成長是由於生醫材料的顯著進步、人口老齡化的擴大、慢性病患病率的顯著增加、再生醫學實踐的支持性監管措施以及患者對器官移植的需求增加。主要原因有以下幾個因素:這些因素共同促進了組織工程和再生醫學領域的成長和發展。

預計未來幾年組織工程市場規模將快速成長。 2028年,將以14.4%的年複合成長率(CAGR)成長至263.3億美元。預測期內的預期成長是由精準醫療方法的採用、對免疫調節技術的日益重視、整形外科治療的更廣泛應用、該領域的資金籌措和投資的增加以及慢性病患病率的增加所推動的。這是由於幾個重要因素因素,包括:這些因素共同推動了組織工程和再生醫學的預期進步。在此期間預計的主要趨勢包括將奈米技術融入方法論、使用先進的3D細胞培養技術、開發和使用晶載技術、將人工智慧融入研究和應用以及創新。包括探索細胞來源。這些趨勢將在預測期內塑造並推動組織工程和再生醫學實踐的發展。

慢性病和創傷性緊急情況的日益流行預計將推動組織工程市場的成長。慢性病的特徵是持續超過 3 個月的持續臨床症狀,通常需要持續治療而無需明確治療方法。另一方面,創傷性緊急情況是指需要立即就醫的突然、嚴重的身體傷害,例如創傷性腦損傷。醫療保健專業人員廣泛採用組織工程,使用各種技術(包括自體移植物、同種異體移植物、異種移植物和合成替代品)來治療慢性疾病和創傷。例如,根據 Mary Ann Liebert & Co. 2021 年 3 月的報告,大約 2% 的美國人口患有慢性傷口,而到 2020 年,美國疾病管制與預防中心(CDC) 記錄了大約64,000 例創傷性傷口。在美國,每天約有 176 人死於腦損傷。這強調了組織工程在解決流行的慢性疾病和創傷緊急情況方面的關鍵作用,推動了組織工程市場的成長。

心血管疾病盛行率的上升預計將進一步促進組織工程市場的成長。心血管疾病,也稱為心血管疾病 (CVD),包括影響心臟和血管的各種醫療狀況。組織工程正在開發修復和再生受損心臟和血管組織的解決方案,提供有前景的治療選擇。根據世界衛生組織(WHO)統計,2021年,每年有超過1500萬年齡在30歲至69歲之間的人死於非傳染性疾病(NCD),其中心血管疾病是最常見的,每年有1790萬人死亡。 死的。這種流行,特別是在低收入和中等收入國家,強調了對有效解決方案的需求,並進一步促進了組織工程市場的成長。組織工程市場的擴張因其在解決各種醫療狀況(從慢性疾病到創傷性緊急情況和心血管疾病)方面的作用而凸顯。

2023年組織工程市場最大的地區是北美。預計亞太地區將成為預測期內組織工程市場成長最快的地區。組織工程市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章組織工程市場特點

第3章 組織工程市場趨勢與策略

第4章組織工程市場-宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章 全球組織工程市場規模及成長

  • 全球市場促進因素與抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長,2023-2028、2033

第6章組織工程市場區隔

  • 全球組織工程市場,按類型、實際和預測細分,2018-2023、2023-2028、2033
  • 合成支架材料
  • 生物來源支架材料
  • 其他類型
  • 全球組織工程市場,按應用、效能和預測細分,2018-2023、2023-2028、2033
  • 整形外科和肌肉骨骼系統
  • 神經病學
  • 心血管
  • 皮膚和體被
  • 牙科
  • 其他用途
  • 全球組織工程市場,按最終用戶細分,實際和預測,2018-2023、2023-2028、2033
  • 醫院和診所
  • 門診設施

第 7 章:組織工程市場區域與國家分析

  • 全球組織工程市場,按地區、績效及預測,2018-2023、2023-2028、2033
  • 全球組織工程市場,依國家、績效及預測,2018-2023、2023-2028、2033

第8章亞太組織工程市場

第9章中國組織工程市場

第10章 印度組織工程市場

第11章 日本組織工程市場

第12章 澳洲組織工程市場

第13章 印尼組織工程市場

第14章 韓國組織工程市場

第15章西歐組織工程市場

第16章英國組織工程市場

第17章 德國組織工程市場

第18章 法國組織工程市場

第19章 義大利組織工程市場

第20章 西班牙組織工程市場

第21章東歐組織工程市場

第22章 俄羅斯組織工程市場

第23章北美組織工程市場

第24章美國組織工程市場

第25章加拿大組織工程市場

第26章 南美洲組織工程市場

第27章 巴西組織工程市場

第28章中東組織工程市場

第29章 非洲組織工程市場

第30章組織工程市場的競爭形勢與公司概況

  • 組織工程市場競爭形勢
  • 組織工程市場公司概況
    • Medtronic plc
    • Zimmer Biomet
    • Allergan plc
    • Organogenesis Holdings Inc.
    • Integra LifeSciences

第31章全球組織工程市場的競爭基準化分析

第32章全球組織工程市場競爭儀表板

第33章組織工程市場重大併購

第34章組織工程市場未來展望及潛力分析

第35章附錄

簡介目錄
Product Code: r11392

“Tissue Engineering Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue engineering? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The tissue engineering market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Synthetic Scaffold Material; Biologically Derived Scaffold Material; Other Types
  • 2) By Application: Orthopedics And Musculoskeletal; Neurology; Cardiovascular; Skin And Integumentary; Dental; Other Applications;;
  • 3) By End-User: Hospitals And Clinics; Ambulatory Facilities
  • Companies Mentioned: Medtronic plc; Zimmer Biomet; Allergan plc; Organogenesis Holdings Inc.; Integra LifeSciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Tissue engineering is a specialized field within biomedical engineering that combines biological and engineering methodologies. It aims to generate three-dimensional tissue and cellular products both in vivo (within a living organism) and in vitro (outside a living organism) by modifying cell growth conditions and utilizing appropriate cell isolates from donor tissues alongside biocompatible scaffold materials. The primary objective is to restore, repair, maintain, or enhance tissue function by replacing or regenerating damaged tissues, thereby improving human body functions.

Key categories within tissue engineering encompass synthetic scaffold materials, biologically derived scaffold materials, and other methodologies. Synthetic scaffold materials are synthetic polymers composed of fibrous proteins that simulate an extracellular matrix, promoting favorable cellular responses and behaviors in tissue engineering applications. These materials find diverse applications across orthopedics and musculoskeletal treatments, neurology, cardiovascular procedures, skin and integumentary therapies, dental applications, among others. Various end-users including hospitals, clinics, and ambulatory facilities utilize these materials for their respective medical applications.

The tissue engineering market research report is one of a series of new reports from The Business Research Company that provides tissue engineering market statistics, including the tissue engineering industry global market size, regional shares, competitors with a tissue engineering market share, detailed tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering industry. This tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue engineering market size has grown rapidly in recent years. It will grow from $13.36 billion in 2023 to $15.38 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth observed in the historic period can be primarily attributed to several factors, including significant advancements in biomaterials, the expanding aging population demographic, a notable increase in the prevalence of chronic diseases, supportive regulatory measures for regenerative medicine practices, and a rising demand from patients for organ transplants. These elements collectively contributed to the growth and development within the field of tissue engineering and regenerative medicine.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The anticipated growth in the forecast period can be attributed to several key factors, including the adoption of precision medicine approaches, a heightened emphasis on immunomodulation techniques, broader applications within orthopedic treatments, augmented funding and investment in the field, and a growing incidence of chronic diseases. These factors collectively drive the anticipated advancements within tissue engineering and regenerative medicine. Major trends expected during this period encompass the integration of nanotechnology into methodologies, the utilization of advanced 3D cell culture techniques, the development and utilization of organ-on-a-chip technology, the integration of artificial intelligence in research and applications, and the exploration of innovative cell sources. These trends are poised to shape and drive the evolution of tissue engineering and regenerative medicine practices in the forecasted period.

The anticipated increase in the prevalence of chronic diseases and trauma emergencies is poised to drive the growth of the tissue engineering market. Chronic diseases are characterized by enduring clinical conditions that persist for three months or longer, often requiring ongoing management without definitive cures. Conversely, trauma emergencies refer to sudden and severe physical injuries necessitating immediate medical attention, such as traumatic brain injuries. Healthcare professionals widely adopt tissue engineering for treating chronic disorders and trauma, employing various techniques such as autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For example, a March 2021 report from Mary Ann Liebert, Inc. indicated that approximately 2% of the total U.S. population is affected by chronic wounds, while in 2020, the Centers for Disease Control and Prevention (CDC) recorded around 64,000 traumatic brain injuries in the United States, resulting in approximately 176 deaths daily due to TBI. This underscores the critical role of tissue engineering in addressing prevalent chronic diseases and trauma emergencies, driving the growth of the tissue engineering market.

The rising prevalence of cardiovascular disorders is expected to further contribute to the growth of the tissue engineering market. Cardiovascular disorders, also known as cardiovascular diseases (CVD), encompass various medical conditions affecting the heart and blood vessels. In tissue engineering, solutions are developed to repair and regenerate damaged cardiac and vascular tissues, offering promising treatment options. According to the World Health Organization in 2021, more than 15 million people aged 30 to 69 die annually from non-communicable diseases (NCDs), with cardiovascular disease being the most common, causing 17.9 million deaths each year. This prevalence, particularly in low- and middle-income countries, emphasizes the demand for effective solutions, further driving the growth of the tissue engineering market. The tissue engineering market's expansion is underscored by its role in addressing a spectrum of medical conditions, from chronic diseases to trauma emergencies and cardiovascular disorders.

Technological advancement stands out as a prominent trend gaining momentum in the tissue engineering market. Major companies within the industry are placing a significant focus on research and development to drive product innovations, providing enhanced solutions and solidifying their market positions. An example of this commitment is CELLINK, a U.S.-based company specializing in tissue engineering, which introduced its advanced bioprinter in March 2021. The BIO MDX Series, operating on 3D bioprinting technology, utilizes bio-inks and living cells to construct natural 3D tissue structures. This innovative technology comprises printheads, nanoliter and picoliter dispensing channels, and robotic integration, enabling precision bioprinting for high-throughput fabrication. The utilization of advanced bioprinting technologies reflects the industry's dedication to pushing the boundaries of tissue engineering for improved outcomes in cell-based technologies.

Major companies are strategically engaging in partnerships and collaborations with start-ups and mid-sized companies to expand their product and service offerings in the tissue engineering market. These collaborative efforts play a crucial role in broadening companies' product portfolios and extending their geographical reach. An illustrative instance is the collaboration agreement between Regen Lab, a Swiss-based medical technology company specializing in tissue engineering, Long Island University (LIU), and the Dassault Systemes Group (3DS) in June 2023. Under this agreement, LIU and RegenLab USA join forces to establish an industrial innovation accelerator, a new center of excellence dedicated to regenerative medicine and tissue engineering. Such strategic collaborations enhance the capabilities and offerings of companies in the tissue engineering market, fostering innovation and growth. LIU, based in the U.S., and Dassault Systemes Group, a French software corporation, are key partners in this initiative.

In October 2022, Geistlich Pharma, a US-based company specializing in bone, cartilage, and tissue regeneration, completed the acquisition of Lynch Biologics, LLC. The financial specifics of this acquisition were not disclosed. This strategic move serves to bolster Geistlich's existing regenerative product portfolio and augments its growth prospects within the field. Lynch Biologics, the acquired company, is also based in the US and is known for its focus on regenerative medicine and tissue engineering. They specialize in supplying advanced biotechnology products aimed at fostering healing and tissue regeneration.

Major companies operating in the tissue engineering market report are Medtronic plc, Zimmer Biomet, Allergan plc, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, Acelity L.P. Inc., B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., Osiris Therapeutics Inc., Organovo Inc., BioTime Inc., Bio Tissue Technologies, Vericel Corporation, Smith and Nephew, Acell Inc., Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Butterfly Network Inc., iThera Medical GmbH, Bit Bio, Be Biopharma Inc., The Takeda Pharmaceutical Company, Frequency Therapeutics, TELA Bio Inc., Orthocell Limited .

North America was the largest region in the tissue engineering market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue engineering market consists of sales of reparative cells, bioreactive molecules, such as cytokines, growth factors, biomaterials, and bioreactors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Tissue Engineering Market Characteristics

3. Tissue Engineering Market Trends And Strategies

4. Tissue Engineering Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Tissue Engineering Market Size and Growth

  • 5.1. Global Tissue Engineering Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Tissue Engineering Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Tissue Engineering Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tissue Engineering Market Segmentation

  • 6.1. Global Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Synthetic Scaffold Material
  • Biologically Derived Scaffold Material
  • Other Types
  • 6.2. Global Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Orthopedics And Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin And Integumentary
  • Dental
  • Other Applications
  • 6.3. Global Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Facilities

7. Tissue Engineering Market Regional And Country Analysis

  • 7.1. Global Tissue Engineering Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Tissue Engineering Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tissue Engineering Market

  • 8.1. Asia-Pacific Tissue Engineering Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tissue Engineering Market

  • 9.1. China Tissue Engineering Market Overview
  • 9.2. China Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tissue Engineering Market

  • 10.1. India Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tissue Engineering Market

  • 11.1. Japan Tissue Engineering Market Overview
  • 11.2. Japan Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tissue Engineering Market

  • 12.1. Australia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tissue Engineering Market

  • 13.1. Indonesia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tissue Engineering Market

  • 14.1. South Korea Tissue Engineering Market Overview
  • 14.2. South Korea Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tissue Engineering Market

  • 15.1. Western Europe Tissue Engineering Market Overview
  • 15.2. Western Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tissue Engineering Market

  • 16.1. UK Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tissue Engineering Market

  • 17.1. Germany Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tissue Engineering Market

  • 18.1. France Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tissue Engineering Market

  • 19.1. Italy Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tissue Engineering Market

  • 20.1. Spain Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tissue Engineering Market

  • 21.1. Eastern Europe Tissue Engineering Market Overview
  • 21.2. Eastern Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tissue Engineering Market

  • 22.1. Russia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tissue Engineering Market

  • 23.1. North America Tissue Engineering Market Overview
  • 23.2. North America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tissue Engineering Market

  • 24.1. USA Tissue Engineering Market Overview
  • 24.2. USA Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tissue Engineering Market

  • 25.1. Canada Tissue Engineering Market Overview
  • 25.2. Canada Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tissue Engineering Market

  • 26.1. South America Tissue Engineering Market Overview
  • 26.2. South America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tissue Engineering Market

  • 27.1. Brazil Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tissue Engineering Market

  • 28.1. Middle East Tissue Engineering Market Overview
  • 28.2. Middle East Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tissue Engineering Market

  • 29.1. Africa Tissue Engineering Market Overview
  • 29.2. Africa Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tissue Engineering Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Engineering Market Competitive Landscape
  • 30.2. Tissue Engineering Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Zimmer Biomet
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Allergan plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Organogenesis Holdings Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Integra LifeSciences
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Tissue Engineering Market Competitive Benchmarking

32. Global Tissue Engineering Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Tissue Engineering Market

34. Tissue Engineering Market Future Outlook and Potential Analysis

  • 34.1 Tissue Engineering Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Tissue Engineering Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Tissue Engineering Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer